FindTrial
Sign In

Does bisphosphonate reduce mortality in patients with hip fractures

Does bisphosphonate reduce mortality in patients with hip fractures

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025658
Enrollment
Unknown
Registered
2019-09-04
Start date
2019-09-02
Completion date
Unknown
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture

Interventions

1:bisphosphonates
2:D3 CaCO3 tabletes

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Hip fractures2. The first hip replacement was performed.3.Complete clinical data.

Exclusion criteria

Exclusion criteria: 1. Those who take drugs affecting bone metabolism in the past year; 2. those with hypocalcemia and vitamin D deficiency; 3. patients with pathological femoral neck fracture; 4. patients with multiple fractures and severe soft tissue injury; 5. patients with severe internal diseases; 6. patients with systemic or local infection.

Design outcomes

Primary

MeasureTime frame
Imaging evaluation;K-M Survival Analysis;Full load-bearing time;SF-36 Score;Complications;Blood routine and other laboratory tests;—

Countries

China

Contacts

Public ContactFeng Shuo

Affiliated Hospital of Xuzhou Medical University

781733181@qq.com+86 18552880088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026